Regeneron Pharmaceuticals other operating income or expenses for the twelve months ending June 30, 2024 were $-0.029B, a 154.12% decline year-over-year.
Regeneron Pharmaceuticals annual other operating income or expenses for 2023 were $0.002B, a 97.66% decline from 2022.
Regeneron Pharmaceuticals annual other operating income or expenses for 2022 were $0.09B, a 97.15% increase from 2021.
Regeneron Pharmaceuticals annual other operating income or expenses for 2021 were $0.046B, a 83.74% decline from 2020.
Regeneron Pharmaceuticals Other Operating Income or Expenses 2010-2024 | REGN